Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.49 USD | +4.53% | +3.41% | -7.75% |
Apr. 19 | Xenon Pharmaceuticals Inc. Announces Board Resignations | CI |
Mar. 11 | Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM |
Financials (USD)
Sales 2024 * | 2.39M | Sales 2025 * | 9.5M | Capitalization | 3.07B |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -260M | EV / Sales 2024 * | 1,048 x |
Net cash position 2024 * | 560M | Net cash position 2025 * | 507M | EV / Sales 2025 * | 270 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
-12.2
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.16% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | -4.87% | ||
1 week | -1.07% | ||
1 month | -5.57% | ||
3 months | -10.11% | ||
6 months | +31.13% | ||
Current year | -11.75% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 16 M€ | -5.68% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 42.49 | +4.53% | 368 985 |
24-04-30 | 40.65 | -4.87% | 595,929 |
24-04-29 | 42.73 | +5.51% | 629,045 |
24-04-26 | 40.5 | +1.00% | 320,772 |
24-04-25 | 40.1 | +1.52% | 255,970 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.75% | 3.07B | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.26% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- XENE Stock